Xin Zou Selected Research

Triglycerides (Triacylglycerol)

8/2011	[Effects of different compatibility proportion of jiaotai pills on treating type 2 diabetes mellitus in rats].
3/2005	Effects of emodin on treating murine nonalcoholic fatty liver induced by high caloric laboratory chaw.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Zou Research Topics

Disease

18	Insulin Resistance 01/2022 - 03/2005
12	Neoplasms (Cancer) 04/2022 - 12/2013
11	Inflammation (Inflammations) 01/2022 - 02/2016
9	Type 2 Diabetes Mellitus (MODY) 03/2021 - 08/2011
8	Body Weight (Weight, Body) 04/2022 - 03/2005
4	Diabetes Mellitus 01/2022 - 07/2013
4	Obesity 01/2021 - 03/2017
4	Sleep Deprivation 03/2020 - 03/2017
4	Hyperlipidemias (Hyperlipidemia) 01/2017 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2018
3	Infections 10/2021 - 11/2008
3	Fibrosis (Cirrhosis) 04/2020 - 01/2016
3	Cognitive Dysfunction 03/2020 - 01/2017
3	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2020 - 03/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2022
2	COVID-19 10/2021 - 04/2020
2	Weight Gain 03/2021 - 01/2021
2	Glucose Intolerance 01/2021 - 07/2015
2	Non-alcoholic Fatty Liver Disease 09/2019 - 03/2005
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2013
2	Hyperglycemia 01/2017 - 01/2013
1	Weight Loss (Weight Reduction) 06/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Glucose Metabolism Disorders 01/2022
1	Glioma (Gliomas) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Erectile Dysfunction 01/2022
1	Carcinogenesis 04/2021
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Exanthema (Rash) 01/2021
1	Colitis 04/2020

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 01/2022 - 03/2005
12	BerberineIBA 04/2022 - 02/2015
12	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2010
11	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 11/2009
8	LipidsIBA 09/2019 - 03/2005
6	jiao tai wanIBA 03/2020 - 01/2013
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2005
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
3	Therapeutic UsesIBA 01/2022 - 12/2013
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 08/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 11/2009
3	isoquinolineIBA 01/2018 - 02/2016
3	AlkaloidsIBA 01/2018 - 02/2016
3	jiaotaiIBA 12/2017 - 08/2011
3	bushen tongmaiIBA 08/2010 - 03/2010
2	CateninsIBA 04/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 03/2020 - 03/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2018
2	dihydroberberineIBA 02/2015 - 11/2009
2	Triglycerides (Triacylglycerol)IBA 08/2011 - 03/2005
2	EnzymesIBA 08/2011 - 03/2005
2	Messenger RNA (mRNA)IBA 08/2010 - 07/2010
1	PolymersIBA 06/2022
1	MetalsIBA 06/2022
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	Monoclonal AntibodiesIBA 04/2022
1	Hepatocyte Nuclear FactorsIBA 04/2022
1	6-methyladenineIBA 01/2022
1	formononetinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Small Nucleolar RNA (snoRNA)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	N-methyladenosineIBA 01/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Neutralizing AntibodiesIBA 10/2021
1	AntibodiesIBA 10/2021
1	celastrolIBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	TriterpenesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Peptides (Polypeptides)IBA 12/2020
1	sym-trinitrobenzeneIBA 04/2020
1	Sulfonic AcidsIBA 04/2020
1	CollagenIBA 04/2020
1	Fibronectins (Fibronectin)IBA 04/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2020
1	Small Cytoplasmic RNAIBA 04/2020
1	NF-kappa B (NF-kB)IBA 02/2020
1	phillyrinIBA 02/2020

Therapy/Procedure

3	Therapeutics 04/2022 - 01/2016
3	Immunotherapy 12/2020 - 01/2020
1	Transplantation 04/2022
1	Aftercare (After-Treatment) 01/2022